Wall Street's Secret Weapon: How Citi and Capital One Cracked the H-1B Code
Wall Street might not be building the next ChatGPT, but it's hiring like it wants to. New data covering May 2020 through 2024 shows that Citigroup (NYSE:C) brought in over 3,000 new H-1B workersmore than many Big Tech names. But here's the kicker: nearly two-thirds weren't even Citi employees. They were contractorslower-paid, outsourced, and funneled in through firms like Tata Consultancy Services, which is now under federal investigation. These middlemen operate a parallel system: they recruit, place, and often underpay talent while clipping a cut from each paycheck. Median salary for one of these H-1B developers? $94,000. Compare that to $142,000 for a direct hire doing similar work.
Warning! GuruFocus has detected 7 Warning Sign with C.
Capital One might just be the poster child for how deep this goes. More than half of its 905 H-1B contract hires came from staffing firms flagged for using multiple registrationsa strategy the government deemed fraudulent just last year. The company worked with 429 separate middlemen, including six previously linked to visa gaming. Other big namesVerizon (NYSE:VZ), AT&T (NYSE:T), Walmart (NYSE:WMT)also relied heavily on such contractors, but remained silent when pressed for comment. Even with similar job titles and education levels, the pay gap between contract and full-time H-1B workers remained stark. In some cases, one in three contractors was paid the bare minimum allowed under US law.
This is no longer just a Silicon Valley story. It's a systemic reshaping of white-collar labor. And the incentives are clear: lower wages, flexible hiring, and easier paths to offshoring. The data, obtained through FOIA litigation, exposes how middlemen now dominate a program once meant to bring in the best of the best. But instead of elite AI talent, we're seeing armies of outsourced IT workers filling lower-level rolesoften stuck in second-tier status due to visa restrictions. Whether Washington reforms it or not, investors would be smart to watch how companies like Citigroup and Capital One are quietly arbitraging America's immigration system.
This article first appeared on GuruFocus.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
43 minutes ago
- Yahoo
What Makes Medtronic a Leader in Medical Devices
Medtronic plc (NYSE:MDT) is one of the Best Wide Moat Dividend Stocks to Invest in. A surgeon in a modern operating room holding advanced medical devices with a sense of purpose and accuracy. The company remains a major player in the medical technology space as it focuses on medical devices. Its broad product lineup targets a variety of chronic conditions, including heart disease, diabetes, chronic pain, and acute care needs. With strengths across several therapeutic areas, the company has multiple paths for growth and holds a strong position in each market it serves. R&D is key in healthcare, often drawing attention to smaller companies with breakthrough potential, but they carry high risk and usually don't pay dividends. Medtronic plc (NYSE:MDT) stands out as a stable, mature firm that offers a dividend. The company has raised its payouts for 48 consecutive years, which means that it's just two years away from becoming a Dividend King. The company pays a quarterly dividend of $0.71 per share and has a dividend yield of 3.30%, as of June 24. Medtronic plc (NYSE:MDT) recently announced that it will spin off its diabetes care division into an independent, publicly traded company within the next 18 months. The move is part of its strategy to streamline operations and focus on core, high-margin growth areas. Although it will part with its fastest-growing segment, Medtronic plc (NYSE:MDT)'s overall business remains strong, with a broad portfolio of products that continue to deliver steady revenue and profits. In a tough market, investors often favor reliable, stable companies like Medtronic. While we acknowledge the potential of MDT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None. Sign in to access your portfolio
Yahoo
43 minutes ago
- Yahoo
Why JNJ Is a Long-Term Winner
Johnson & Johnson (NYSE:JNJ) is one of the Best Wide Moat Dividend Stocks to Invest in. A smiling baby with an array of baby care products in the foreground. Johnson & Johnson (NYSE:JNJ) is a long-established leader in the healthcare industry, with a strong portfolio of high-performing drugs in areas like immunology and cancer treatment, along with a thriving medical devices business. In 2023, the company separated its slower-growing consumer health segment, which includes well-known products such as Band-Aids and Tylenol, by launching it as an independent publicly listed firm called Kenvue (KVUE). In times of economic uncertainty, large and reputable healthcare companies like Johnson & Johnson (NYSE:JNJ) are often considered reliable investment options. The company currently offers a dividend yield of 3.4%. While the dividend remains steady and continues to grow, the stock price itself can vary significantly from year to year. The company holds one of the longest dividend growth streaks in the market, spanning 63 years. It offers a quarterly dividend of $1.30 per share. In March, Johnson & Johnson (NYSE:JNJ) announced plans to increase its investment in US operations, committing more than $55 billion over the next four years to develop new manufacturing and research facilities. This represents a 25% increase compared to its investment over the previous four years. While we acknowledge the potential of JNJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
What happened to NIO stock and is it still worth considering?
NIO (NYSE:NIO) stock, once a darling of the electric vehicle (EV) boom, has slumped over the past two years. After peaking during the pandemic-era EV frenzy, NIO shares have continued to tumble. Even now, it's trading towards the lower end of its 52-week average. So what's happened? Well, the reasons behind this decline are multifaceted, with both company-specific and sector-wide challenges weighing on sentiment. The primary factor is persistent losses and a delayed path to profitability. NIO's not expected to turn a profit until 2028, according to consensus analyst estimates. That's three years from now. In 2028, the price-to-earnings (P/E) ratio would be 19 times earnings. That's a little demanding for three years' time, but this figure can plummet in the early years of profitability. This prolonged loss-making status is a red flag for many investors, especially as competition in the EV sector intensifies. NIO's recent earnings reports have disappointed. While sales volumes are rising, average selling prices have fallen, and costs in the sector remain stubbornly high. The company's net debt position has also become a concern, as it continues to fund operations and expansion through borrowing. That puts pressure on its balance sheet and raises questions about future dilution or refinancing risks. Despite the gloom, NIO's top-line growth remains robust. Consensus estimates call for annual EPS growth of 28% in 2025, accelerating to over 40% by 2027. Yet, with net losses persisting and debt mounting, the market's patience is wearing thin. Investors should also be wary that NIO has missed targets before. I'd also argue that NIO's battery-swapping technology is becoming less valuable. A few years ago, the idea that you could swap your battery in a matter of minutes rather than charging a car for an hour seemed like a great idea. However, building battery-swapping station is a massive logistical cost. Meanwhile, conventional charging times have plummeted. Another dynamic shaping the sector is the growing focus on autonomous driving. Markets are becoming less enamoured with pure-play EV makers and more interested in companies with credible self-driving technology. In fact, Elon Musk told us years ago that there was no money in cars. While NIO's made investments in smart driving features, it faces stiff competition from both domestic rivals and global giants like Tesla, who are pouring billions into autonomous systems. The ability to differentiate on software and self-driving capabilities may ultimately determine who wins in the next phase of automotive disruption. For risk-tolerant investors, NIO could be a passable opportunity as average share price targets suggest it could recover. However, with persistent losses, a heavy debt load, and intensifying competition, the risks are substantial. Until NIO demonstrates a clear path to profitability and stronger financial discipline, its shares may remain under pressure. Personally, I don't think the stock's worth considering. The post What happened to NIO stock and is it still worth considering? appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool James Fox has no position in any of the shares mentioned. The Motley Fool UK has recommended Tesla. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Sign in to access your portfolio
